Search Videos and More
When a Mystery Illness Actually Has a Fix: New Hope for Patient with Brain Condition
NPH is most common in adults aged 60 and up, and symptoms vary from person to person. Some 800,000 Americans are living with NPH, says the Hydrocephalus Association, yet it’s estimated that 80 percent remain untreated or undiagnosed.Miami Cancer Institute and Miami Cancer Institute – Plantation –Earn APEx Reaccreditation and New Accreditation in Radiopharmaceutical Therapy
Miami Cancer Institute and Miami Cancer Institute – Plantation have been awarded APEx reaccreditation and new accreditation in radiopharmaceutical therapy, reinforcing their continued excellence in radiation oncology and commitment to evidence-based, patient-centered care.Transcranial Magnetic Stimulation (TMS) Gave Him His Life Back
Prefrontal TMS therapy is a noninvasive neuromodulation technique approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in patients whose symptoms have not responded to medications or psychotherapy.When Total Ankle Replacement May Be the Best Choice for Your Patients
Total ankle replacement (TAR) is emerging as an increasingly attractive option for many patients with end-stage ankle arthritis.Elevating Sarcoma Care: Multidisciplinary Collaboration and Innovation in Rare Cancer Treatment Page Summary
Sarcomas remain one of the most diverse and challenging cancer types to diagnose and treat. Baptist Health Cancer Care continues to advance care through coordinated expertise, early detection efforts, and emerging research opportunities.Making the Right Valve Call
Making the Right Valve Call, an interactive webinar led by Baptist Health Heart & Vascular Care experts, explore the latest evidence-based strategies for selecting the most appropriate valve therapy approach for patients with structural heart disease.Novel PET Radiotracer at Baptist Health Miami Cardiovascular Institute Improves Detection of Coronary Artery Disease
Miami Cardiac & Vascular Institute is among the first in the U.S. to offer flurpiridaz F-18, a groundbreaking PET radiotracer recently approved by the U.S. Food and Drug Administration.Medical Physics Residency Program Preps Future Generation of Experts
At Baptist Health Miami Cancer Institute, a team of 26 medical physicists partner with radiation oncologists to craft individualized treatment strategies that push the boundaries of what’s possible in radiation therapy.Inaugural Scholars Program at Boca Raton Regional Hospital Honors Three Marcus Neuroscience Institute Physicians
These Scholars, generously funded by the Marcus Foundation, Inc., are now able to learn more about the causes and treatment of disorders affecting the nervous system — not only from a scientific perspective but also by examining how society and systems contribute to these issues.Multidisciplinary Valve Expertise, Exceptional Outcomes Why Referring Physicians Trust Baptist Health for Heart Valve Disease Care
An estimated 2.5% of the U.S. population is affected by valvular heart disease, with prevalence increasing sharply with age. In fact, up to 13% of people over 75 have moderate or severe valve disease,Pivotal Presentations That May Shape the Breast Cancer Standard of Care
Anticipated updates in key breast cancer clinical trials at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting underscore “the importance of continued innovation in breast cancer therapy,” according to Reshma L. Mahtani, DO.Enhancing NSCLC Brain Metastasis Treatment With MR-Guided Ultrasound: Manmeet Ahluwalia, MD, MBA, FASCO
Combining magnetic resonance (MR)-guided focused ultrasound with microbubbles and immune checkpoint inhibitors (ICIs) could transform non-small cell lung cancer (NSCLC) treatment by reducing radiation side effects.
